Emerging biosensor technologies for obstructive sleep apnea: A comprehensive overview and future prospects.

Chih-Wei Tsai¹, Lydia Leung¹, Hung Tat Chen¹, Ka Cheung Kwok¹, Michelle Lee², Ambrose A Chiang³

¹Belun Technology Company Limited, Hong Kong, Hong Kong.

²Belun Technology Company Limited, Hong Kong, Hong Kong; Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, Hong Kong.

³Division of Sleep Medicine, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, United States; Division of Pulmonary, Critical Care, and Sleep Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Department of Medicine, Case Western Reserve University, Cleveland, OH, United States. Electronic address: Ambrose.chiang@va.gov.

PubMed DOI

Abstract

Obstructive sleep apnea (OSA) is a pervasive disorder characterized by recurrent airway obstructions during sleep. OSA carries serious health risks, such as cardiovascular and cognitive impairments, and imposes a significant economic burden. This chapter provides a comprehensive overview of various biosensors currently employed for OSA detection, including in-lab polysomnography and flow-based hom…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.